Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia.
about
Role of human papillomaviruses in carcinogenesisCervical cancer screening in developing countries at a crossroad: Emerging technologies and policy choicesHuman papillomavirus and cervical cancer: biomarkers for improved prevention effortsThe Application of Classification and Regression Trees for the Triage of Women for Referral to Colposcopy and the Estimation of Risk for Cervical Intraepithelial Neoplasia: A Study Based on 1625 Cases with Incomplete Data from Molecular Tests.Depletion of the cdk inhibitor p16INK4a differentially affects proliferation of established cervical carcinoma cells.Prevalence of human papillomavirus16 DNA and p16INK4a protein in oral squamous cell carcinoma: A systematic review and meta-analysisProspects for prevention of HPV-driven oropharynx cancer.Nucleic acid sequence-based amplification assay for human papillomavirus mRNA detection and typing: evidence for DNA amplification.Cervical histopathology variability among laboratories: a population-based statewide investigation[Computer-assisted diagnostics in cervical cytology].Computerized delineation of nuclei in liquid-based pap smears stained with immunohistochemical biomarkers.Triage of HPV-positive women in cervical cancer screening.[Molecular diagnosis of HPV infections].Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population.The specificity and patterns of staining in human cells and tissues of p16INK4a antibodies demonstrate variant antigen binding.Prognostic value of HPV E6/E7 mRNA assay in women with negative colposcopy or CIN1 histology result: a follow-up study.Human papillomavirus testing in the prevention of cervical cancerThe role of inflammation in HPV infection of the Oesophagus.Overexpression of p16(INK4a) in urothelial carcinoma in situ is a marker for MAPK-mediated epithelial-mesenchymal transition but is not related to human papillomavirus infection.Triage of HR-HPV positive women with minor cytological abnormalities: a comparison of mRNA testing, HPV DNA testing, and repeat cytology using a 4-year follow-up of a population-based study.Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6/E7 mRNA assay as a triage test for cervical cytology and HPV DNA testClinical Implication of p16, Ki-67, and Proliferating Cell Nuclear Antigen Expression in Cervical Neoplasia: Improvement of Diagnostic Accuracy for High-grade Squamous Intraepithelial Lesion and Prediction of Resection Margin Involvement on ConizatiBiomarkers of cervical dysplasia and carcinomaPresence of High-Risk HPV mRNA in Relation to Future High-Grade Lesions among High-Risk HPV DNA Positive Women with Minor Cytological AbnormalitiesType-specific human papillomavirus E6/E7 mRNA detection by real-time PCR improves identification of cervical neoplasia.Next Generation Cancer Protection: The Bivalent HPV Vaccine for FemalesP16 and Ki-67 expression improves the diagnostic accuracy of cervical lesions but not predict persistent high risk human papillomavirus infection with CIN1.Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling.HPV-16/18 detection does not affect the prognosis of head and neck squamous cell carcinoma in younger and older patients.Prevalence of human papilloma virus in cytological abnormalities: Association of risk factors and cytomorphological findings.Laboratory and clinical aspects of human papillomavirus testingOptimizing technology for cervical cancer screening in high-resource settings.A review of methods for detect human Papillomavirus infectionA comparison of human papillomavirus genotype-specific DNA and E6/E7 mRNA detection to identify anal precancer among HIV-infected men who have sex with men.Vulvar intraepithelial neoplasia grade 3 associated with Behçet's diseaseEvaluation of Ki67, p16 and CK17 Markers in Differentiating Cervical Intraepithelial Neoplasia and Benign Lesions.HPV-based Tests for Cervical Cancer Screening and Management of Cervical Disease.p16(INK4a) immunohistochemistry is a promising biomarker to predict the outcome of low grade cervical intraepithelial neoplasia: comparison study with HPV genotypingCharacterization of p16 and E6 HPV-related proteins in uterine cervix high-grade lesions of patients treated by conization with large loop excisionMicroRNA-331-3p Suppresses Cervical Cancer Cell Proliferation and E6/E7 Expression by Targeting NRP2
P2860
Q22305628-4178FA9B-FA75-40FC-9F57-A87128246150Q26775085-8AC95100-E6E7-4DAB-B510-616E0784A635Q27023127-BBD70A37-8DD9-47CA-A089-E49DAC6EAAA6Q30991531-08FC982F-C959-4454-8DD1-E38290A096A2Q33602929-8EE3F493-F8C3-40A7-97E8-F23C9552CB06Q33608386-C76DF95C-B7DA-4607-A8F9-6F3ECA0694CFQ33759930-82C16D81-6978-44E2-B078-F8F19F1FB17FQ33963645-EEE31FCC-108A-46D4-B163-291589B0D9BFQ34017556-1A390303-E877-436A-BAF5-20CCB5739DE2Q34061705-B1CEAAE0-4D8F-4F40-830C-9A2496997108Q34301277-21FC0ADC-44CC-424F-8F28-AD6100C94E48Q34344762-E0D5074E-4E46-460B-B26F-9D32108674C3Q34543310-A6F63BE4-C927-4333-8991-D74246340CD9Q34543338-B8EFD625-C94C-482D-AAA8-734DDBD3A33DQ34544920-796CC8ED-0840-49AA-959C-D9F75FB1B919Q34608714-A17E6A72-4F69-43BC-BF9D-279CC792D0C2Q34616083-CD9FA7B7-0A20-441A-A9C0-B0519019F40DQ34660442-21EB6056-9BC2-40E9-A9CA-094D45B2EA97Q34750035-A7996987-4E30-4656-AC93-5F312D9D36F1Q35108590-384D6D0B-76E8-4617-86B9-083707B8F088Q35140046-F04EE227-CEBD-43E0-BED0-A2095C7B655BQ35261428-EE3F9D98-DFCD-4155-A915-81358EEED19DQ35495173-20EB325A-41D0-4506-BF2B-268F1263ECD6Q35498040-AB2E7D39-E3FB-4E98-8E4F-C681732D440DQ35530550-B57295CC-ECD6-4DBE-8CF3-B7452298C58EQ35550810-743E297A-BB9A-411E-BDD6-A5597C65051EQ35632240-F878E4C4-4160-4D11-8B73-7BFBFCD2F2E5Q35796047-4072B015-757B-4A4F-A3A7-4AE646B06DD2Q35995194-6FCFD640-E2E4-463D-8CB8-D59CB08EE2A1Q36231207-96DC7703-EF3E-4906-AFF3-EEE422C782A9Q36311573-0AF5F68A-DDF3-4825-A079-D13D51BA005CQ36319941-7273E497-1AFE-4F68-A750-D9C4B7BD88C2Q36427451-62B40319-18B8-4FB3-9F9D-A3646EA410B8Q36514226-FE459949-A48A-4360-A8C7-970778619D8FQ36694554-E176C7D9-7E46-4778-8A17-3357F6710861Q36813062-B6E84019-5365-4101-B47D-2724039C9F06Q36856284-6E0979EB-42C3-4258-ACF9-8C72CC21B1CCQ37022506-6E6CB02D-946F-436E-922F-D967719B67A4Q37093527-80CD1F80-6FD4-47E5-9E42-FC2CB59DBC0CQ37210229-4C738467-1820-4503-B531-9571500253AF
P2860
Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Human papillomavirus mRNA and ...... agnosis of cervical neoplasia.
@ast
Human papillomavirus mRNA and ...... agnosis of cervical neoplasia.
@en
type
label
Human papillomavirus mRNA and ...... agnosis of cervical neoplasia.
@ast
Human papillomavirus mRNA and ...... agnosis of cervical neoplasia.
@en
prefLabel
Human papillomavirus mRNA and ...... agnosis of cervical neoplasia.
@ast
Human papillomavirus mRNA and ...... agnosis of cervical neoplasia.
@en
P2860
P1476
Human papillomavirus mRNA and ...... agnosis of cervical neoplasia.
@en
P2093
Kate Cuschieri
P2860
P304
P356
10.1158/1055-9965.EPI-08-0306
P577
2008-10-01T00:00:00Z